Key result
Multimodality imaging provides complementary diagnostic and management guidance in hypertrophic cardiomyopathy.
Why the study?
HCM is a common cardiomyopathy with complex genomics, pathophysiology, and diverse phenotypic profiles, where advancements in multimodality imaging have emerged as central to diagnosis and risk stratification.
What is the role of cardiac multimodality imaging in the diagnosis, management, and risk stratification of patients with hypertrophic cardiomyopathy?
What is the role of cardiac multimodality imaging in the diagnosis, management, and risk stratification of patients with hypertrophic cardiomyopathy?
Highlights the indispensable and complementary roles of echocardiography, CMR, and CT in diagnosing, phenotyping, and risk-stratifying patients with hypertrophic cardiomyopathy.
Answers are grounded in this paper and cite their sources.
Supports multimodality imaging consideration in HCM; leaves open need for prospective outcome validation.
Hypertrophic cardiomyopathy (HCM), now recognized as a common cardiomyopathy of complex genomics and pathophysiology, is defined by the presence of left ventricular hypertrophy of various morphologies and severity, significant hemodynamic consequences, and diverse phenotypic, both structural and clinical, profiles. Advancements in cardiac multimodality imaging, including echocardiography, cardiac magnetic resonance imaging, and cardiac computed tomography, with and without angiography have greatly improved the diagnosis of HCM, and enable precise measurements of cardiac mass, volume, wall thickness, function, and physiology. Multimodality imaging provides comprehensive and complementary information and hasemerged as the bedrock for the diagnosis, clinical assessment, serial monitoring, and sudden cardiac death risk stratification of patients with HCM. This review highlights the role of cardiac multimodality imaging in the modern diagnosis and management of HCM.
No takes yet. Share an insight, caveat, or question.
Bukharovich et al. (2023) conducted a review in Hypertrophic cardiomyopathy (HCM). Cardiac multimodality imaging (echocardiography, CMR, CCT) was evaluated. Cardiac multimodality imaging, including echocardiography, CMR, and CCT, provides comprehensive and complementary information essential for the diagnosis and management of hypertrophic cardiomyopathy.
Synapse has enriched 10 related papers. Consider them for comparative context: